Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.
G
G

Gilead

Balita

Reuters - 1 linggo ang nakaraan

U.S. STOCKS Gold miners, Nikola, Cruise stocks

BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, Nikola, Cruise stocks Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Chip stocks boosted the Nasdaq on Monday, while the S&P 500 and the Dow edged lower as investors awaited a key inflation reading, commentary from Federal Reserve Chair Jerome Powell and the start of corporate earnings season for monetary policy cues.
C
G
I
J
N
Q
T
U
U
R
S
V
F
M
Reuters - 1 linggo ang nakaraan

U.S. STOCKS Ally Financial, Ideaya Biosciences, Brinker

BUZZ-U.S. STOCKS ON THE MOVE-Ally Financial, Ideaya Biosciences, Brinker Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq and the S&P 500 hit record highs on Monday, while the Dow scaled a more than one-month high as investors awaited a key inflation report, Congressional testimony from Federal Reserve Chair Jerome Powell and the start of earnings season this week.
B
C
G
I
J
N
Q
T
U
U
H
S
V
F
M
Reuters - 1 linggo ang nakaraan

U.S. STOCKS Boeing, Gilead Sciences, Bumble

BUZZ-U.S. STOCKS ON THE MOVE-Boeing, Gilead Sciences, Bumble Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were on track for a listless open on Monday, in a week packed with crucial inflation readings, Congressional testimony from Federal Reserve Chair Jerome Powell and the start of the corporate earnings season.
B
G
T
U
H
S
F
Reuters - 1 linggo ang nakaraan

Gilead Sciences rises as brokerage upgrades to 'outperform'

BUZZ-Gilead Sciences rises as brokerage upgrades to 'outperform' ** Gilead Sciences' GILD.O shares rise 3.1% to $68.74 premarket ** Brokerage Raymond James raises its rating on company's shares to "outperform" from "market perform" ** Outstanding data from a study of Gilead's long-acting drug lenacapavir in HIV and expected approval of liver diseas
G
Reuters - 2 linggo ang nakaraan

Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change Tesla Inc TSLA.OQ +6.5% NVIDIA Corp NVDA.OQ +4.6% Broadcom Inc AVGO.OQ +4.3% Micron Technology Inc MU.OQ +3.2% Arm Holdings PLC ARM.OQ +2.9% Bottom Performers Percent Change Walgreens Boots Alliance Inc WBA.OQ -4.1% Gilead Sciences Inc GILD.OQ -2.6% Regeneron Pharmaceuticals Inc REGN.OQ -2.0% Biogen Inc BIIB.OQ -1.8% O'Reilly Automotive Inc ORLY.OQ -1.6% The Nasdaq 100 .NDX gained
B
B
G
M
N
R
T
W
U
Reuters - 2 linggo ang nakaraan

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change Paramount Global PARA.OQ +6.9% First Solar Inc FSLR.OQ +6.6% Tesla Inc TSLA.OQ +6.5% Vistra Corp VST.N +4.6% NVIDIA Corp NVDA.OQ +4.6% Bottom Performers Percent Change Walgreens Boots Alliance Inc WBA.OQ -4.1% Constellation Brands Inc
G
N
T
W
U
Reuters - 3 linggo ang nakaraan

Cellares Kite, A Gilead Company, Will Evaluate Co's Automated Manufacturing Platform Cell Shuttle

BRIEF-Cellares Kite, A Gilead Company, Will Evaluate Co's Automated Manufacturing Platform Cell Shuttle June 27 (Reuters) - Gilead Sciences Inc GILD.O : CELLARES: KITE, A GILEAD COMPANY, WILL EVALUATE CO'S AUTOMATED MANUFACTURING PLATFORM CELL SHUTTLE Source text for Eikon: ID:nBw10TJNsa Further company coverage: GILD.O
G
Reuters - 3 linggo ang nakaraan

U.S. stocks weekly: Heat advisory

RPT-BUZZ-U.S. stocks weekly: Heat advisory Repeats from Friday with no changes to text. Updates chart ** S&P 500 .SPX gains third consecutive week, advances 0.6% .N ** Indeed, benchmark index heating up just as summer solstice hits ** And Nasdaq .IXIC ekes out third-straight weekly gain, though it may be flying on fumes ** Most sectors toasty; Consumer Discretionary and Energy bake most, while Tech and bond-proxies cool off; this, as Growth .IGX was on pace for its best month vs Value .IVX in 24
A
A
G
M
N
U
U
Reuters - 3 linggo ang nakaraan

U.S. CarMax, Eli Lilly, MicroStrategy

U.S. RESEARCH ROUNDUP-CarMax, Eli Lilly, MicroStrategy June 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CarMax, Eli Lilly and MicroStrategy, on Monday. HIGHLIGHTS * CarMax Inc KMX.N : RBC raises target price to $75 from $73 * Eli Lilly LLY.N : Jefferies raises target price to $1,015 from $994 * MicroStrategy Inc MSTR.O : Canaccord Genuity cuts target price to $1,826 from $2,047 * Sharecare Inc SHCR.O : Canacco
A
A
B
D
G
M
N
V
E
F
T
E
P
R
T
C
C
I
Reuters - 4 linggo ang nakaraan

U.S. stocks weekly: Heat advisory

BUZZ-U.S. stocks weekly: Heat advisory ** S&P 500 .SPX gains third consecutive week, advances 0.6% .N ** Indeed, benchmark index heating up just as summer solstice hits ** And Nasdaq .IXIC ekes out third-straight weekly gain, though it may be flying on fumes ** Most sectors toasty; Consumer Discretionary and Energy bake most, while Tech and bond-proxies cool off; this, as Growth .IGX was on pace for its best month vs Value .IVX in 24 years, before stumbling relatively last 3 trading days of the
A
A
G
M
N
U
U
Reuters - 4 linggo ang nakaraan

U.S. STOCKS FactSet, Ryan Specialty, Sarepta

BUZZ-U.S. STOCKS ON THE MOVE-FactSet, Ryan Specialty, Sarepta Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street was set for a muted open on Friday as chip stocks lost ground, with focus on data from the manufacturing and services sectors for more clues on the health of the world's largest economy.
A
B
C
G
M
N
N
U
U
C
F
Reuters - 4 linggo ang nakaraan

U.S. STOCKS Apple, Gilead, Spirit Aerosystems

BUZZ-U.S. STOCKS ON THE MOVE-Apple, Gilead, Spirit Aerosystems Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures edged lower on Friday as megacap tech and chip stocks lost ground, with investors awaiting manufacturing and services sectors surveys for more clues on the health of the world's largest economy.
A
B
G
M
N
N
S
R
U
E
C
Reuters - 4 linggo ang nakaraan

Wall Street set for muted open as investors await business survey data

US STOCKS-Wall Street set for muted open as investors await business survey data For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Spirit Aero up following report of Boeing nearing buyout deal Sarepta surges on expanded use of gene therapy Gilead gains after long-acting HIV drug trial success S&P 500 crossed 5,500 points on Thursday Futures down: Dow 0.12%, S&P 500 0.08%, Nasdaq 0.01% Updated at 8:45 a.m.
A
B
G
M
N
Q
U
U
U
Reuters - 4 linggo ang nakaraan

Gilead set to extend gains on success of long-acting HIV drug trial

BUZZ-Gilead set to extend gains on success of long-acting HIV drug trial Updates ** Shares of drugmaker Gilead Sciences GILD.O rise 3.2% to $70.7 premarket following HIV drug trial success reported on Thursday ** Stock closed 5% higher a day earlier on the news, after rising as much as 8.5% during the session ** Co's late-stage study showed injectable drug lenacapavir was more effective in preventing HIV infection in women versus its existing daily pill Truvada ** There were zero incidents of HI
G
Reuters - 4 linggo ang nakaraan

Wall Street futures muted ahead of business survey data

US STOCKS-Wall Street futures muted ahead of business survey data For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Spirit Aero up following report of Boeing nearing buyout deal Sarepta surges on expanded use of gene therapy Gilead gains after long-acting HIV drug trial success Futures: Dow, S&P 500, Nasdaq flat Updated at 7:29 a.m.
B
G
M
M
N
Q
U
U
U
Reuters - 4 linggo ang nakaraan

U.S. STOCKS Apple, Gilead, Spirit Aerosystems

BUZZ-U.S. STOCKS ON THE MOVE-Apple, Gilead, Spirit Aerosystems Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures edged lower on Friday as megacap tech and chip stocks lost ground, with investors awaiting manufacturing and services sectors surveys for more clues on the health of the world's largest economy.
A
B
G
M
N
N
R
U
C
Reuters - 4 linggo ang nakaraan

Wall Street futures edge lower ahead of business survey data

US STOCKS-Wall Street futures edge lower ahead of business survey data For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Futures lower: Dow 0.07%, S&P 500 0.15%, Nasdaq 0.12% June 21 (Reuters) - U.S. stock index futures edged lower on Friday as megacap tech and chip stocks lost ground, with investors awaiting manufacturing and services sectors surveys for more clues on the health of the world's largest economy.
A
B
G
M
N
Q
U
U
U
Reuters - 4 linggo ang nakaraan

Gilead up over long-acting HIV drug trial success

BUZZ-Gilead up over long-acting HIV drug trial success ** Shares of drugmaker Gilead Sciences GILD.O rise 7.3% to $73.5 premarket over Thursday's HIV drug trial success ** Co's late-stage study showed its injectable drug, lenacapavir, was more effective in preventing HIV infection in women versus its existing daily pill Truvada, sending GILD's shar
G
Reuters - 4 linggo ang nakaraan

Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change Gilead Sciences Inc GILD.OQ +8.3% Advanced Micro Devices Inc AMD.OQ +5.2% Sirius XM Holdings Inc SIRI.OQ +3.6% Cognizant Technology Solutions Corp CTSH.OQ +3.5% Workday Inc WDAY.OQ +3.1% Bottom Performers Percent Change Qualcomm Inc QCOM.OQ -5.1% Micron Technology Inc MU.OQ -5.1% Microchip Technology Inc MCHP.OQ -4.5% ON Semiconductor Corp ON.OQ -4.2% Broadcom Inc AVGO.OQ -3.3% Th
B
C
G
M
Q
A
M
O
S
U
W
Reuters - 4 linggo ang nakaraan

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change Gilead Sciences Inc GILD.OQ +8.4% Accenture PLC ACN.N +7.9% Epam Systems Inc EPAM.N +6.3% Salesforce Inc CRM.N +5.1% WestRock Co WRK.N +4.8% Bottom Performers Percent Change Jabil Inc JBL.N -11.2% Enphase Energy Inc ENPH.OQ -8.7% Chipo
C
G
M
Q
S
U
E
W

Kundisyon

Mga Patok na Assets

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.